Grifols Sounds with a lot of strength to give surname to the Camp Nou

The Barcelona of Josep Maria Bartomeu has objective very ambitious, and one of them is definitely the 'Espai Barça'. In addition to taking care the sportive plot, neither forgets his image of mark, and in the weeks to come could know which will be the company that fund the reform of the new Camp Nou, in addition to the derivative installations like the Palau Blaugrana and the new Estadi.

The first phase of the works already gave beginning in the coliseo Barcelona, but his big stage of development is foreseen for next summer and, before this give beginning, from the managerial board of Bartomeu wants to have smart the agreement with the company chosen to sponsor the works, with what the term would finish around the last day of LaLiga Santander, foreseen for the weekend of the 11 and 12 May 2019.

According to the informations launched in the last hours by 'RAC1', in any case, said agreement could arrive a lot before. And it is that it has gone back to plant to the pharmaceutical company Grifols like the main candidate to do with the sponsorship of the works of the 'Espai Barça', being able to give surname therefore to the Camp Nou whenever it launch a proposal that convince to the club.

In the last reports enciphered the planned income by this agreement in near of 200 million euros, but the good answer of the beaux would have increased the quantity until brushing the 300. Now, it touches to negotiate and they have gone descartando some offers, with several American and Asian companies that when seeming were very interested in collaborating with a so powerful mark like the Barça.

Now, Grifols would be the best situated, and before it finish 2018 could close a sponsorship that would lengthen during some 20 years, what would suppose an enormous economic contribution for the arks of the FC Barcelona and that it would be key, without place to doubts, to initiate the project of the construction of the new Camp Nou without putting in danger to the club to economic level.

Grifols, a pharmaceutical giant

Grifols Is an important pharmaceutical company established in Catalonia, and that contributes in the Ibex 35. With some 20.000 workers and chaired by Víctor Grifols, suffices with saying that only in 2016 his turnover arrived to the 4.049,8 million euros, when treating of one of the main world-wide manufacturers of drugs and other therapeutic products. The agreement with the FC Barcelona would be near, as it ensured 'RAC1' in the last hours, but to day of today all would be carrying with a big hermetismo in both parts.